Journal of Sleep Disorders & Therapy
Open Access
ISSN: 2167-0277
ISSN: 2167-0277
Consultant for SensIQ, New Jersey, USA
Research Article
Open-Label Observational Study of a Natural Supplement Containing Nootropics and Adaptogenic Mushrooms in Adults Reporting Symptoms Consistent with Chronic Insomnia
Author(s): Luke Barr MD and Debra Kimless MD*
Background: Sleep disturbances affect up to one-third of adults in the United States and are associated with adverse health and quality-of-life outcomes. Conventional pharmaceutical treatments are often limited by side effects and risk of dependency, prompting interest in well-tolerated, natural alternatives.
Objective: To evaluate the short-term acceptability and efficacy of SensIQ Sleep, a novel supplement containing ashwagandha, valerian root, l-theanine, and reishi mushroom, in adults with chronic insomnia symptoms.
Methods: In this open-label, proof-of-concept study, 38 participants with chronic sleep complaints were enrolled and received weight-based nightly dosing of SensIQ Sleep for 7 days. Sleep quality was assessed before and after the intervention using the PROMIS Sleep Disturbance 8a questionnaire, the .. View More»